Patents by Inventor Xiao Lewell

Xiao Lewell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20070082912
    Abstract: Compounds of formula (I) or a pharmaceutically acceptable derivative thereof: wherein A, R1, R2a, R2b, Rx, R8, and R9 are as defined in the specification, a process for the preparation of such compounds, pharmaceutical compositions comprising such compounds and the use of such compounds in medicine.
    Type: Application
    Filed: May 30, 2003
    Publication date: April 12, 2007
    Inventors: Gerard Giblin, Adrian Hall, Mark Healy, Xiao Lewell, Neil Miller, Riccardo Novelli
  • Publication number: 20070072906
    Abstract: Compounds of formula (I) or a derivative thereof: wherein A, B, Z, R1, R2a, R2b, Rx, R6, and R9 are as defined in the specification, a process for the preparation of such compounds, pharmaceutical compositions comprising such compounds and the use of such compounds in medicine.
    Type: Application
    Filed: November 30, 2004
    Publication date: March 29, 2007
    Inventors: Gerard Giblin, Adrian Hall, Mark Healy, Francis King, Xiao Lewell, Neil Miller, Alan Naylor, Riccardo Novelli
  • Publication number: 20070060596
    Abstract: Compounds of formula (I) or a pharmaceutically acceptable derivative thereof: wherein W, X, Y, Z, R1, R2a, R2b, and Rx, R8 and R9 are as defined in the specification, a process for the preparation of such compounds, pharmaceutical compositions comprising such compounds and the use of such compounds in medicine.
    Type: Application
    Filed: October 21, 2004
    Publication date: March 15, 2007
    Inventors: Gerard Giblin, Adrian Hall, David Hurst, Xiao Lewell, Olivier Lorthioir, Stephen Mickeown, Tiziana Scoccitti, Stephen Watson
  • Publication number: 20060079525
    Abstract: There are provided according to the invention, novel compounds of formula (I) wherein R1, R2, R3, R4, R5, X, a, b and Z are as defined in the specification, processes for preparing them, formulations containing them and their use in therapy for the treatment of inflammatory diseases.
    Type: Application
    Filed: November 22, 2005
    Publication date: April 13, 2006
    Inventors: Rachael Ancliff, Caroline Cook, Colin Eldred, Paul Gore, Lee Harrison, Simon Hodgson, Duncan Judd, Suzanne Keeling, Xiao Lewell, Graeme Robertson, Stephen Swanson
  • Publication number: 20060063765
    Abstract: Compounds of formula (I): wherein: R1 represents substituted or unsubstituted heteroaryl; Y represents ā€”(CRnaRnb)nā€”; Rna and Rnb are each independently hydrogen or C1-6alkyl; n is an integer from 0 to 5; R2 represents unsubstituted or substituted aryl or unsubstituted or substituted heteroaryl; R3 and R4 each independently represent hydrogen or C1-6alkyl; R7 represents hydrogen or C1-6alkyl; R8 represents hydrogen or C1-6alkyl; and salts and solvates thereof; are CCR3 antagonists and are thus indicated to be useful in therapy.
    Type: Application
    Filed: March 27, 2003
    Publication date: March 23, 2006
    Inventors: Rachael Ancliff, Caroline Cook, Colin Eldred, Paul Gore, Lee Harrison, Martin Hayes, Simon Hodgson, Duncan Judd, Suzanne Keeling, Xiao Lewell, Gail Mills, Graeme Robertson, Stephen Swanson, Andrew Walker, Mark Wilkinson
  • Publication number: 20060058299
    Abstract: Compound of formula (I): and salts and solvates thereof, a process for its preparation, pharmaceutical formulations containing it and its use in therapy.
    Type: Application
    Filed: March 27, 2003
    Publication date: March 16, 2006
    Inventors: Rachael Ancliff, Caroline Cook, Colin Eldred, Paul Gore, Lee Harrison, Martin Hayes, Simon Hodgson, Duncan Judd, Suzanne Keeling, Xiao Lewell, Gail Mills, Graeme Robertson, Stephen Swanson, Andrew Walker, Mark Wilkinson
  • Publication number: 20050239802
    Abstract: Compounds of formula (I) or a pharmaceutically acceptable derivative thereof: wherein A, R1, R2, Rx, R8, R9 and n are as defined in the specification, a process for the preparation of such compounds, pharmaceutical compositions comprising such compounds and the use of such compounds in medicine.
    Type: Application
    Filed: April 7, 2003
    Publication date: October 27, 2005
    Inventors: Gerard Martin Giblin, Adrian Hall, David Hurst, Ian Kilford, Xiao Lewell, Alan Taylor, Riccardo Novelli